Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03604588
What this trial is testing

Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers

Who this might be right for
Oropharyngeal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 40
Testing effectiveness (Phase 2)Ended earlyNCT03646461
What this trial is testing

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and Neck
University of California, San Diego 5
Large-scale testing (Phase 3)UnknownNCT00336947
What this trial is testing

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Yokohama City University 500
Testing effectiveness (Phase 2)Study completedNCT04251949
What this trial is testing

Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.

Who this might be right for
Oral CancerOropharyngeal Cancer
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)Looking for participantsNCT06445114
What this trial is testing

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CancerCarcinoma
Zachary Zumsteg 50
Not applicableEnded earlyNCT01891695
What this trial is testing

OPSCC N0 Nodal Control With Reduced IMRT

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)HPV (Human Papillomavirus)-Associated
Paul W. Read, MD 1
Not applicableActive Not RecruitingNCT02945631
What this trial is testing

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

Who this might be right for
Locally Advanced HPV Positive Oropharynx Cancer
Icahn School of Medicine at Mount Sinai 43
Early research (Phase 1)Study completedNCT00049166
What this trial is testing

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer

Who this might be right for
Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+3 more
National Cancer Institute (NCI) 48
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Early research (Phase 1)Study completedNCT00486304
What this trial is testing

Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy

Who this might be right for
CachexiaHead and Neck CancerWeight Changes
UNC Lineberger Comprehensive Cancer Center 4
Not applicableStudy completedNCT03239834
What this trial is testing

Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making

Who this might be right for
Palatal NeoplasmsLip NeoplasmGingival Neoplasms+4 more
Vigilant Biosciences, Inc. 893
Early research (Phase 1)Active Not RecruitingNCT05540899
What this trial is testing

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of the Larynx+2 more
American College of Radiology 14
Not applicableStudy completedNCT02405000
What this trial is testing

Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance

Who this might be right for
Oropharyngeal Cancer
Dartmouth-Hitchcock Medical Center 23
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Large-scale testing (Phase 3)Active Not RecruitingNCT01266044
What this trial is testing

Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia

Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 435
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Not applicableStudy completedNCT00526851
What this trial is testing

Oral Cancer Screening Among Nursing Home Dentists in Ohio

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 37
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Study completedNCT01316757
What this trial is testing

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Fox Chase Cancer Center 24
Next Page